Ownership Summary
A total of 4 institutions have reported a stake in China Pharma Holdings, Inc. (NYSE:CPHI) as of December 2025, according to recent 13F filings with the SEC.
- Institutional ownership in China Pharma Holdings edged down to 0.8% in December 2025, compared to 1.6% in September 2025.
- In percentage terms, this reflects as a holdings change of -1.73% quarter on quarter, and a decrease of 42.86% year over year.
- During the quarter, 3 institutions bought more China Pharma Holdings shares, 1 sold shares, and 0 of the 4 total investors held their position steady.
- The aggregate institutional position in China Pharma Holdings now stands at 29.29K shares as of December 2025, after investors decreased their holdings (down by 515 shares quarter on quarter which is down 144.53K shares year over year).
- As of December 31, 2025, DRW Securities, LLC held China Pharma Holdings's largest shareholding position with over 17.42K shares, representing 0.45% of total outstanding shares.
- Among the most significant buyers of China Pharma Holdings during December 2025 were DRW Securities, LLC (17.42K), RENAISSANCE TECHNOLOGIES LLC (700), EFG International AG (40).
- Leading sellers of China Pharma Holdings stock in December 2025 included UBS Group AG (18.68K).
- The top 4 institutional holders of China Pharma Holdings for the quarter ending December 2025 included DRW Securities, LLC (17.42K), RENAISSANCE TECHNOLOGIES LLC (11.32K), UBS Group AG (513), EFG International AG (40).